Volume 5, Issue 5, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Advertisements

Mira Park, Ph. D. , Dae-Shik Suh, M. D. , Kangseok Lee, Ph. D
Volume 11, Issue 2, Pages (August 2012)
Volume 8, Issue 5, Pages (May 2017)
DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer  Yi-Chieh Yang, MS, Yen-An Tang,
Volume 138, Issue 1, Pages e3 (January 2010)
Volume 9, Issue 5, Pages (November 2017)
Volume 55, Issue 1, Pages (July 2014)
Volume 6, Issue 5, Pages (May 2010)
Jurian Schuijers, Laurens G. van der Flier, Johan van Es, Hans Clevers 
Volume 22, Issue 18, Pages (September 2012)
Volume 47, Issue 2, Pages (July 2012)
Volume 9, Issue 1, Pages (July 2017)
Volume 138, Issue 1, Pages e3 (January 2010)
M. Ushita, T. Saito, T. Ikeda, F. Yano, A. Higashikawa, N. Ogata, U
A Gene Regulatory Network Controls the Binary Fate Decision of Rod and Bipolar Cells in the Vertebrate Retina  Sui Wang, Cem Sengel, Mark M. Emerson,
Volume 12, Issue 3, Pages (July 2015)
Volume 28, Issue 1, Pages (January 2014)
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Volume 57, Issue 2, Pages (January 2015)
Volume 13, Issue 6, Pages (December 2013)
P63 Transcription Factor Regulates Nuclear Shape and Expression of Nuclear Envelope-Associated Genes in Epidermal Keratinocytes  Valentina Rapisarda,
Promoting Myelin Repair through In Vivo Neuroblast Reprogramming
Volume 13, Issue 1, Pages (July 2013)
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Volume 5, Issue 1, Pages (July 2015)
Volume 5, Issue 1, Pages (July 2003)
Volume 16, Issue 3, Pages (November 2004)
Volume 23, Issue 5, Pages (November 2012)
Volume 16, Issue 3, Pages (March 2015)
Volume 15, Issue 7, Pages (May 2016)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 22, Issue 2, Pages (February 2012)
Volume 17, Issue 1, Pages (September 2016)
Volume 4, Issue 5, Pages (May 2015)
Volume 10, Issue 4, Pages (April 2018)
Volume 143, Issue 1, Pages (October 2010)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
A Sox Transcription Factor Is a Critical Regulator of Adult Stem Cell Proliferation in the Drosophila Intestine  Fanju W. Meng, Benoît Biteau  Cell Reports 
Jamie A. Hackett, Toshihiro Kobayashi, Sabine Dietmann, M. Azim Surani 
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer
Volume 9, Issue 6, Pages (December 2017)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 25, Issue 13, Pages e5 (December 2018)
Transient Expression of WNT2 Promotes Somatic Cell Reprogramming by Inducing β- Catenin Nuclear Accumulation  Mizuki Kimura, May Nakajima-Koyama, Joonseong.
Volume 70, Issue 5, Pages (June 2011)
Volume 5, Issue 3, Pages (September 2015)
Volume 4, Issue 1, Pages (January 2015)
Volume 2, Issue 3, Pages (September 2012)
Impact of Swiprosin-1/Efhd2 on Adult Hippocampal Neurogenesis
GRM7 Regulates Embryonic Neurogenesis via CREB and YAP
Volume 10, Issue 4, Pages (April 2018)
Volume 5, Issue 5, Pages (November 2015)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation  Amy Q. Lu, Evgenya Y. Popova, Colin.
Volume 20, Issue 13, Pages (September 2017)
Volume 9, Issue 5, Pages (November 2017)
EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy
Repression of COUP-TFI Improves Bone Marrow-Derived Mesenchymal Stem Cell Differentiation into Insulin-Producing Cells  Tao Zhang, Xiao-Hang Li, Dian-Bao.
Volume 7, Issue 5, Pages (November 2016)
Klotho is a target gene of PPAR-γ
Volume 16, Issue 3, Pages (July 2016)
CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State
Defining the Regulatory Elements in the Proximal Promoter of ΔNp63 in Keratinocytes: Potential Roles for Sp1/Sp3, NF-Y, and p63  Rose-Anne Romano, Barbara.
Volume 20, Issue 13, Pages (September 2017)
Transient Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important Early Step in Reprogramming to Pluripotency  Shuo Wang, Pengyan.
Volume 17, Issue 3, Pages (October 2016)
Volume 55, Issue 1, Pages (July 2014)
Presentation transcript:

Volume 5, Issue 5, Pages 805-815 (November 2015) Enhancer Analysis Unveils Genetic Interactions between TLX and SOX2 in Neural Stem Cells and In Vivo Reprogramming  Mohammed M. Islam, Derek K. Smith, Wenze Niu, Sanhua Fang, Nida Iqbal, Guoqiang Sun, Yanhong Shi, Chun-Li Zhang  Stem Cell Reports  Volume 5, Issue 5, Pages 805-815 (November 2015) DOI: 10.1016/j.stemcr.2015.09.015 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Cis-Regulatory Elements within the Tlx Locus (A) Conservatory genomic elements and their role in controlling gene expression in neural stem cells (NSCs). The indicated elements were examined for driving gene expression in either cultured cells (X, not expressed; U, ubiquitous; N, NSCs) or transgenic mice (LacZ/total, LacZ+ embryos over the total number of transgenic embryos). (B) Brain-restricted reporter expression controlled by the identified two enhancers. Embryonic day (E) 12.5–13.5 embryos were stained for β-galactosidase activity. (C) Enh1 is active in both embryonic and postnatal stages. NSCs are marked with NES staining, while enhancer activity is indicated by staining for β-galactosidase (β-gal). E12.5, embryonic day 12.5; P28, postnatal day 28. The scale bar represents 50 μm. (D) Enhancer activity of Enh2 is developmentally regulated. The scale bar represents 50 μm. (E) Genomic conservation of the indicated enhancer region. (F) The highly conserved genomic sequence drives reporter expression (blue signal) in the developing CNS. See also Figure S1. Stem Cell Reports 2015 5, 805-815DOI: (10.1016/j.stemcr.2015.09.015) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Core Sequences Controlling Gene Expression in TLX+ Cells (A) Relative sequence locations within the indicated Tlx enhancer. (B) Analyzing enhancer activity through in vivo electroporation of P0 mouse brains. (C) Representative fluorescence images showing transcriptional activity of the indicated genomic sequences. tdTomato under the constitutively active CAG promoter was used as an internal control for electroporation. The ratios of GFP+ cells over tdTomato+ cells are indicated in the parentheses (n = 3 mice; mean ± SEM). LV, lateral ventricle. The scale bar represents 50 μm. (D) Immunohistochemistry showing enhancer activity in TLX+ NSCs. Higher magnification views of the arrow-indicated cells are also shown. The scale bar represents 50 μm. See also Table S1. Stem Cell Reports 2015 5, 805-815DOI: (10.1016/j.stemcr.2015.09.015) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Transcription Factors Regulating Tlx Enhancer Activity (A) A diagram showing locations of the consensus transcription factor binding sequences (BS). (B) Diminished enhancer activity with mutations in the SOX2- or MYT1-binding sequences. Constitutively expressed tdTomato was used as an internal control for electroporation. The ratios of GFP+ cells over tdTomato+ cells are indicated in the parentheses (n = 3 mice; mean ± SEM). The scale bar represents 50 μm. (C) MYT1 directly binds to the identified enhancer. Antibody-induced supershift in electrophoresis mobility shift assays (EMSA) is shown in the boxed region. Normal IgG was used as controls for EMSA and chromatin immunoprecipitation (ChIP) assays (mean ± SEM; n = 3 independent experiments for control IgG and MYT1 antibody). (D) SOX2 directly binds to the identified enhancer. The boxed region shows antibody-induced supershift of the probe. Normal IgG was used as controls for EMSA and ChIP (mean ± SEM; n = 3 independent experiments for control IgG and SOX2 antibody). See also Table S2. Stem Cell Reports 2015 5, 805-815DOI: (10.1016/j.stemcr.2015.09.015) Copyright © 2015 The Authors Terms and Conditions

Figure 4 MYT1 Regulates Tlx Enhancer Activity (A) A western blot analysis showing shRNA-mediated downregulation of MYT1. β-actin was used as a loading control. (B) Knocking down endogenous MYT1 reduces transcriptional activity of the core enhancer (Enh1.1.3). shRNA-expressing cells are marked by GFP. The scale bar represents 100 μm. (C) Immunohistochemistry showing TLX expression in cells with the indicated shRNA. The scale bar represents 100 μm. (D) Downregulation of MYT1 modestly reduces the number of TLX-expressing cells (mean ± SEM; n = 3 mice for each shRNA; ∗p < 0.05 by Student’s t test). See also Table S3. Stem Cell Reports 2015 5, 805-815DOI: (10.1016/j.stemcr.2015.09.015) Copyright © 2015 The Authors Terms and Conditions

Figure 5 SOX2 Controls Tlx Enhancer Activity and Endogenous Expression (A) Immunohistochemistry showing enhancer activity in cells with the indicated shRNA. The co-electroporated tdTomato was used as an internal control. The scale bar represents 50 μm. (B) Downregulation of SOX2 greatly reduces Enh1.1 activity (mean ± SEM; n = 3 mice for each shRNA; ∗p < 0.001 by Student’s t test). (C) Downregulation of SOX2 greatly reduces Enh1.1.3 activity (mean ± SEM; n = 3 mice for each shRNA; ∗p < 0.001 by Student’s t test). (D) Quantification of SOX2 knockdown efficiency. shRNA-expressing cells are indicated by the co-electroporated GFP marker (mean ± SEM; n = 3 mice for each shRNA; ∗p < 0.01 by Student’s t test). (E) Downregulation of SOX2 dramatically reduces TLX expression (mean ± SEM; n = 3 mice for each shRNA; ∗p < 0.01 by Student’s t test). (F) Immunohistochemistry showing expression of the indicated markers. The scale bar represents 50 μm. See also Table S3. Stem Cell Reports 2015 5, 805-815DOI: (10.1016/j.stemcr.2015.09.015) Copyright © 2015 The Authors Terms and Conditions

Figure 6 SOX2 Requires TLX to Induce Neurogenesis in the Adult Striatum (A) TLX is required for SOX2-mediated in vivo reprogramming. Tlx was conditionally deleted in astrocytes of pGFAP-Cre;Tlxflox/flox mice. DCX+ cells were quantified by immunohistochemistry (IHC) at 5 weeks post SOX2 virus injection in the adult striatum (mean ± SEM; n = 6 and 4 mice for Cre− and Cre+ groups, respectively; ∗p < 0.001 by Student’s t test). (B) Representative confocal images showing SOX2-induced DCX+ cells in the striatum of mice with the indicated genetic background. Hst, Hoechst 33342 dye. The scale bar represents 50 μm. (C) Quantification of transcription factor-induced neuroblasts in the adult striatum. DCX+ cells were determined by IHC at 5 weeks post virus injection in the adult mouse striatum (mean ± SEM; n = 5 mice for Ascl1, n = 5 mice for Tlx, n = 4 mice for Sox2, and n = 4 mice for Tlx+Sox2; ND, not detected; ∗p < 0.01 by Student’s t test). (D) Immunofluorescence showing TLX-induced DCX+ neuroblasts in the adult mouse striatum. GFP alone was used as a control. An enlarged view of a DCX+ cell in the boxed region is also shown. LV, lateral ventricle. The scale bar represents 1 mm (lower magnification views) and 50 μm (higher magnification views). Stem Cell Reports 2015 5, 805-815DOI: (10.1016/j.stemcr.2015.09.015) Copyright © 2015 The Authors Terms and Conditions